BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34465625)

  • 21. CHD3 and CHD4 recruitment and chromatin remodeling activity at DNA breaks is promoted by early poly(ADP-ribose)-dependent chromatin relaxation.
    Smith R; Sellou H; Chapuis C; Huet S; Timinszky G
    Nucleic Acids Res; 2018 Jul; 46(12):6087-6098. PubMed ID: 29733391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
    Zhang L; Li DQ
    Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A PARP1-BRG1-SIRT1 axis promotes HR repair by reducing nucleosome density at DNA damage sites.
    Chen Y; Zhang H; Xu Z; Tang H; Geng A; Cai B; Su T; Shi J; Jiang C; Tian X; Seluanov A; Huang J; Wan X; Jiang Y; Gorbunova V; Mao Z
    Nucleic Acids Res; 2019 Sep; 47(16):8563-8580. PubMed ID: 31291457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CHD1L Regulated PARP1-Driven Pluripotency and Chromatin Remodeling During the Early-Stage Cell Reprogramming.
    Jiang BH; Chen WY; Li HY; Chien Y; Chang WC; Hsieh PC; Wu P; Chen CY; Song HY; Chien CS; Sung YJ; Chiou SH
    Stem Cells; 2015 Oct; 33(10):2961-72. PubMed ID: 26201266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells.
    Verma P; Zhou Y; Cao Z; Deraska PV; Deb M; Arai E; Li W; Shao Y; Puentes L; Li Y; Patankar S; Mach RH; Faryabi RB; Shi J; Greenberg RA
    Nat Cell Biol; 2021 Feb; 23(2):160-171. PubMed ID: 33462394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous dual-channel imaging to quantify interdependent protein recruitment to laser-induced DNA damage sites.
    Garbrecht J; Hornegger H; Herbert S; Kaufmann T; Gotzmann J; Elsayad K; Slade D
    Nucleus; 2018; 9(1):474-491. PubMed ID: 30205747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of Nucleosome Reorganization by PARP1.
    Maluchenko NV; Nilov DK; Pushkarev SV; Kotova EY; Gerasimova NS; Kirpichnikov MP; Langelier MF; Pascal JM; Akhtar MS; Feofanov AV; Studitsky VM
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PARP1 enhances inflammatory cytokine expression by alteration of promoter chromatin structure in microglia.
    Martínez-Zamudio RI; Ha HC
    Brain Behav; 2014 Jul; 4(4):552-65. PubMed ID: 25161822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly(ADP-ribose) polymerase 1 (PARP1) promotes oxidative stress-induced association of Cockayne syndrome group B protein with chromatin.
    Boetefuer EL; Lake RJ; Dreval K; Fan HY
    J Biol Chem; 2018 Nov; 293(46):17863-17874. PubMed ID: 30266807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of Poly(ADP-Ribose) Polymerase 1 Activity by Y-Box-Binding Protein 1.
    Naumenko KN; Sukhanova MV; Hamon L; Kurgina TA; Alemasova EE; Kutuzov MM; Pastré D; Lavrik OI
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32947956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling.
    van Beek L; McClay É; Patel S; Schimpl M; Spagnolo L; Maia de Oliveira T
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPF1 and nucleosomes mediate a dramatic switch in activity of PARP1 from polymerase to hydrolase.
    Rudolph J; Roberts G; Muthurajan UM; Luger K
    Elife; 2021 Mar; 10():. PubMed ID: 33683197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic insight into the role of Poly(ADP-ribosyl)ation in DNA topology modulation and response to DNA damage.
    Matkarimov BT; Zharkov DO; Saparbaev MK
    Mutagenesis; 2020 Feb; 35(1):107-118. PubMed ID: 31782485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PARP1 exhibits enhanced association and catalytic efficiency with γH2A.X-nucleosome.
    Sharma D; De Falco L; Padavattan S; Rao C; Geifman-Shochat S; Liu CF; Davey CA
    Nat Commun; 2019 Dec; 10(1):5751. PubMed ID: 31848352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human PARP1 Facilitates Transcription through a Nucleosome and Histone Displacement by Pol II In Vitro.
    Kotova EY; Hsieh FK; Chang HW; Maluchenko NV; Langelier MF; Pascal JM; Luse DS; Feofanov AV; Studitsky VM
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. XPC-PARP complexes engage the chromatin remodeler ALC1 to catalyze global genome DNA damage repair.
    Blessing C; Apelt K; van den Heuvel D; Gonzalez-Leal C; Rother MB; van der Woude M; González-Prieto R; Yifrach A; Parnas A; Shah RG; Kuo TT; Boer DEC; Cai J; Kragten A; Kim HS; Schärer OD; Vertegaal ACO; Shah GM; Adar S; Lans H; van Attikum H; Ladurner AG; Luijsterburg MS
    Nat Commun; 2022 Aug; 13(1):4762. PubMed ID: 35963869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elucidation of the functional roles of the Q and I motifs in the human chromatin-remodeling enzyme BRG1.
    Hoffmeister H; Fuchs A; Strobl L; Sprenger F; Gröbner-Ferreira R; Michaelis S; Hoffmann P; Nazet J; Merkl R; Längst G
    J Biol Chem; 2019 Mar; 294(9):3294-3310. PubMed ID: 30647132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A quantitative assay reveals ligand specificity of the DNA scaffold repair protein XRCC1 and efficient disassembly of complexes of XRCC1 and the poly(ADP-ribose) polymerase 1 by poly(ADP-ribose) glycohydrolase.
    Kim IK; Stegeman RA; Brosey CA; Ellenberger T
    J Biol Chem; 2015 Feb; 290(6):3775-83. PubMed ID: 25477519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Enigmatic Function of PARP1: From PARylation Activity to PAR Readers.
    Kamaletdinova T; Fanaei-Kahrani Z; Wang ZQ
    Cells; 2019 Dec; 8(12):. PubMed ID: 31842403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PARP1-modulated chromatin remodeling is a new target for cancer treatment.
    Sinha S; Molla S; Kundu CN
    Med Oncol; 2021 Aug; 38(10):118. PubMed ID: 34432161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.